TRAF3IP1
TRAF3-interacting protein 1
Also known as: DKFZP434F124, FAP116, IFT54, MIP-T3, MIPT3, MIPT3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDR0
- Gene
- TRAF3IP1
- Ensembl
- ENSG00000204104
- Chromosome
- 2
- Canonical length
- 691 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Primary cilium transition zone
OverviewNCBI Gene
The protein encoded by this gene interacts with TNF receptor-associated factor 3, tethering it to cytoskeletal microtubules. The encoded protein is also an inhibitor of the innate type I IFN response. Defects in this gene are a cause of Senior-Loken syndrome 9. [provided by RefSeq, Mar 2017]
Canonical amino-acid sequenceUniProt
691 residues, UniProt reviewed canonical sequence.
>Q8TDR0|TRAF3IP1
1 MNAAVVRRTQ EALGKVIRRP PLTEKLLSKP PFRYLHDIIT EVIRMTGFMK GLYTDAEMKS
61 DNVKDKDAKI SFLQKAIDVV VMVSGEPLLA KPARIVAGHE PERTNELLQI IGKCCLNKLS
121 SDDAVRRVLA GEKGEVKGRA SLTSRSQELD NKNVREEESR VHKNTEDRGD AEIKERSTSR
181 DRKQKEELKE DRKPREKDKD KEKAKENGGN RHREGERERA KARARPDNER QKDRGNRERD
241 RDSERKKETE RKSEGGKEKE RLRDRDRERD RDKGKDRDRR RVKNGEHSWD LDREKNREHD
301 KPEKKSASSG EMSKKLSDGT FKDSKAETET EISTRASKSL TTKTSKRRSK NSVEGRKEDN
361 ISAKSLDSIV SGINNEPNQE TTTSEIGTKE ANINSTSISD DNSASLRCEN IQPNPTEKQK
421 GDSTSDAEGD AGPAGQDKSE VPETPEIPNE LSSNIRRIPR PGSARPAPPR VKRQDSMEAL
481 QMDRSGSGKT VSNVITESHN SDNEEDDQFV VEAAPQLSEM SEIEMVTAVE LEEEEKHGGL
541 VKKILETKKD YEKLQQSPKP GEKERSLFES AWKKEKDIVS KEIEKLRTSI QTLCKSALPL
601 GKIMDYIQED VDAMQNELQM WHSENRQHAE ALQQEQRITD CAVEPLKAEL AELEQLIKDQ
661 QDKICAVKAN ILKNEEKIQK MVYSINLTSR RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAF3IP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 18 nTPM
- testis: 13 nTPM
- epididymis: 12 nTPM
- parathyroid gland: 11 nTPM
- skeletal muscle: 11 nTPM
- blood vessel: 11 nTPM
Single-cell type
- respiratory ciliated cells: 475 nCPM
- endometrial ciliated cells: 357 nCPM
- fallopian tube ciliated cells: 344 nCPM
- ependymal cells: 186 nCPM
- pituicytes/fscs: 151 nCPM
- choroid plexus epithelial cells: 129 nCPM
Immune cell
- NK-cell: 2 nTPM
- non-classical monocyte: 1.4 nTPM
- MAIT T-cell: 0.6 nTPM
- memory CD8 T-cell: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- choroid plexus: 19 nTPM
- midbrain: 19 nTPM
- medulla oblongata: 18 nTPM
- spinal cord: 17 nTPM
- pons: 16 nTPM
- hypothalamus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRAF3IP1.
Disease | AllUniProt
Conditions TRAF3IP1 is implicated in, by any mechanism.
- Senior-Loken syndrome 9 (SLSN9) MIM:616629
Disease | GeneticClinVar
35 pathogenic / likely-pathogenic of 680 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Senior-Loken syndrome 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- defense response to virus
- dorsal/ventral neural tube patterning
- embryonic camera-type eye development
- embryonic digit morphogenesis
- embryonic heart tube development
- intraciliary anterograde transport
- intraciliary transport
- kidney development
- morphogenesis of a polarized epithelium
- negative regulation of defense response to virus
- negative regulation of interferon-beta production
- negative regulation of protein phosphorylation
- negative regulation of protein-containing complex assembly
- negative regulation of smoothened signaling pathway
- negative regulation of type I interferon production
- post-anal tail morphogenesis
- regulation of microtubule cytoskeleton organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TRAF3-interacting protein 1
- TRAF3-interacting protein 1, N-terminal
- TRAF3-interacting protein 1, C-terminal domain
- TRAF3-interacting protein 1, N-terminal domain superfamily
- Microtubule-binding protein MIP-T3 CH-like domain
- Microtubule-binding protein MIP-T3 C-terminal region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAF3IP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAF3IP1 as an antibody target. Whether an autoantibody or antibody against TRAF3IP1 could matter depends on whether native TRAF3IP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAF3IP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAF3IP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...